158 related articles for article (PubMed ID: 23499501)
21. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
Thompson RH; Dong H; Kwon ED
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
[TBL] [Abstract][Full Text] [Related]
22. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
23. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
[TBL] [Abstract][Full Text] [Related]
24. Regulation of beta1 integrin expression by PKCepsilon in renal cancer cells.
Brenner W; Benzing F; Gudejko-Thiel J; Fischer R; Färber G; Hengstler JG; Seliger B; Thüroff JW
Int J Oncol; 2004 Oct; 25(4):1157-63. PubMed ID: 15375568
[TBL] [Abstract][Full Text] [Related]
25. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
[TBL] [Abstract][Full Text] [Related]
26. Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
Ku BM; Kim DS; Kim KH; Yoo BC; Kim SH; Gong YD; Kim SY
FASEB J; 2013 Sep; 27(9):3487-95. PubMed ID: 23704086
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine.
Meyer N; Duensing S; Anastassiou G; Brevis Nunez F; Grosse J; Ganser A; Atzpodien J
Anticancer Res; 1999; 19(2C):1509-12. PubMed ID: 10365134
[TBL] [Abstract][Full Text] [Related]
28. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
29. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.
Yuan J; Takahashi A; Masumori N; Itoh N; Tsukamoto T
Int J Urol; 2006 Mar; 13(3):265-70. PubMed ID: 16643621
[TBL] [Abstract][Full Text] [Related]
31. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
32. Clusterin plays an important role in clear renal cell cancer metastasis.
Wang X; Luo L; Dong D; Yu Q; Zhao K
Urol Int; 2014; 92(1):95-103. PubMed ID: 24008723
[TBL] [Abstract][Full Text] [Related]
33. Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
Liu QZ; Gao XH; Chang WJ; Gong HF; Fu CG; Zhang W; Cao GW
Int J Clin Exp Pathol; 2015; 8(10):12802-10. PubMed ID: 26722470
[TBL] [Abstract][Full Text] [Related]
34. Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
Waalkes S; Eggers H; Blasig H; Atschekzei F; Kramer MW; Hennenlotter J; Tränkenschuh W; Stenzl A; Serth J; Schrader AJ; Kuczyk MA; Merseburger AS
Biomark Med; 2011 Apr; 5(2):219-25. PubMed ID: 21473727
[TBL] [Abstract][Full Text] [Related]
35. Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression.
Kruck S; Bedke J; Hennenlotter J; Ohneseit PA; Kuehs U; Senger E; Sievert KD; Stenzl A
Oncol Rep; 2010 Jan; 23(1):159-63. PubMed ID: 19956876
[TBL] [Abstract][Full Text] [Related]
36. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
37. Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers.
Cho SY; Oh Y; Jeong EM; Park S; Lee D; Wang X; Zeng Q; Qin H; Hu F; Gong H; Liu X; Zhang G; Na D; Lee J; Chae J; Suh YS; Kong SH; Lee HJ; Kim JI; Park H; Zhang C; Yang HK; Lee C
Exp Mol Med; 2020 May; 52(5):854-864. PubMed ID: 32467608
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
40. Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens.
Kusuda Y; Miyake H; Behnsawy HM; Fukuhara T; Inoue TA; Fujisawa M
Urol Oncol; 2013 Jan; 31(1):42-50. PubMed ID: 21396851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
